RE:RE:Tweed's Fins are Out :)The financials are for a 5 period fiscal and include many large one time costs including listing fees of $1M and aquisition of "Tweed Farms" for another million.
What's exciting is that their sales are almost doubling every quarter with the last Q bringing in more than 50% of total sales.
They are also showing a negative cost of goods sold because they are just cloning the same plant over and over. It's a pretty amazing margin!
Near term marketing and sales costs will be high as they slowly convert the medical community to switch medications but with a growth rate in Q5 of 91% you can't say they're not doing their jobs.